Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction

European Journal of Cancer Prevention

Volumn 10, Issue 6, 2001, Pages 483-487

  Conio, M ^a   Filiberti, R ^a   Blanchi, S ^a   Giacosa, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Barrett's oesophagus; Cancer of the cardia; Cancer prevention; Carditis; Intestinal metaplasia; Oesophageal adenocarcinoma

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CARDIA; CARDITIS; DIET; DISEASE COURSE; DYSPLASIA; ENVIRONMENTAL FACTOR; ESOPHAGEAL ADENOCARCINOMA; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; PRECANCER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SQUAMOUS EPITHELIUM; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARDIA; DISEASE PROGRESSION; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; METAPLASIA; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0035679917     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200112000-00002     Document Type: Review

References (69)

1. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus
2. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
3. Continued climb in rates of esophageal adenocarcinoma: An update
4. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
5. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma
6. Epidemiology of columnar-lined esophagus and adenocarcinoma
7. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
8. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus
9. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus
10. An initial comparison of nine centres registering patients with the UK National Barrett's Oesophagus Registry (UKBOR)
11. Significance of intestinal metaplasia in different areas of the esophagus including esophagogastric junction
12. Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis
13. An inverse relation between cagA + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
14. Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia
15. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
16. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota
17. 'Carditis': An objective histological marker for pathologic gastroesophageal reflux disease
18. The rising incidence of gastric cardia
19. Relationship of Helicobacter pylori infection to several malignant and non-malignant gastrointestinal diseases
20. The gastric cardia in Helicobacter pylori infection
21. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H. pylori infection
22. Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia
23. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?
24. Barrett's esophagus: Development of dysplasia and adenocarcinoma
25. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985
26. Diet and cancer: A review of scientific evidence
27. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data
28. The prevalence and clinical characteristics of short segments of specialised intestinal metaplasia in the distal esophagus on routine endoscopy
29. Screening for specialized columnar epeithelium with methylene blue: Chromoendoscopy in patients with Barrett's esophagus and a normal control group
30. The gastric cardia: Fact or fiction?
31. Case-control study of methionine, nitriten and salt on gastric carcinogenesis in Northern Italy
32. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
33. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
34. Inflammation of the gastro-esophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: A prospective study
35. Bile in the oesophagus: Clinical relevance and ambulatory detection
36. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus
37. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
38. Intestinal metaplasia of the gastric cardia
39. Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia
40. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease
41. Citokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus
42. Role of Helicobacter pylori cagA + strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia
43. The rising trend in oesophageal adenocarcinoma and gastric cardia
44. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus
45. The biopsy diagnosis of gastroesophageal reflux disease, 'carditis', and Barrett's esophagus, and sequelae of therapy
46. Is there a GERD gene?
47. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma
48. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus
49. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia
50. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
51. Adenocarcinoma arising in tongues of short segments of Barrett's esophagus
52. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia
53. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction
54. Barrett's esophagus
55. Prevalence of metaplasia at the gastro-oesophageal junction
56. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities?
57. Familial clustering of reflux symptoms
58. Adenocarcinoma in Barrett's esophagus: An overrated risk
59. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma
60. Analysis of gastroduodenitis and oesophagitis in relation to dyspeptic/reflux symptoms
61. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease
62. Short segment Barrett's esophagus: Clinical and histological features, associated endoscopic findings and association with gastric intestinal metaplasia
63. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus
64. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity
65. Barrett's esophagus: Prevalence and incidence of adenocarcinoma
66. Association of obesity with hiatal hernia and esophagitis
67. Cigarette smoking and esophageal and gastric cardia adenocarcinoma
68. Adenocarcinoma of the esophagus and gastric cardia: The role of diet
69. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach